1 recruiting, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Thromboinflammation: new trials by email Literature Review of Thromboinflammation trials Research Report on Thromboinflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| "IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ" Anakinra 100Mg/0.67Ml Inj Syringe - Pancreatic Transplant | Phase 1 / Phase 2 | Recruiting | Nantes University Hospital | 15 | 2026-10-07 | 2026-10-13 |
| Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19 Bemiparin - Covid-19 | Phase 2 | Terminated | Fundación de investigación HM | 81 | 2020-06-04 | 2022-06-07 |
COVID-19 (1)
Blood Coagulation Disorders (2) · Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Thrombosis (2) · Vascular Diseases (2) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1)
Interleukin 1 Receptor Antagonist Protein (1) · bemiparin (1)
Fundación de investigación HM (1) · Nantes University Hospital (1)
France (1) · Spain (1)